Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 6-demethyl-6-desoxytetracycline
2. 6-deoxy-6-demethyltetracycline
3. 6-desoxy-6-demethyltetracyclin
4. 6-dodmtc
5. Bonomycin
6. Sancycline Hydrochloride
1. 808-26-4
2. Bonomycin
3. Norcycline
4. 6-demethyl-6-deoxytetracycline
5. Sancyclinum
6. Sancycline Free Base
7. Gs 2147
8. Odn00f2sjg
9. Gs-2147
10. 808-26-4 (free Base)
11. 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
12. Sanciclina
13. (4s,4as,5ar,12ar)-4-(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide
14. (4s,4as,5ar,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
15. (4s,4as,5ar,12as)-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
16. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4s,4as,5ar,12as)-
17. Nsc51812
18. Sancycline [usan:inn]
19. Sancyclinum [inn-latin]
20. Unii-odn00f2sjg
21. Sanciclina [inn-spanish]
22. Nsc 51812 (as Hydrochloride)
23. Bonomycin (tn)
24. Sancycline [mi]
25. Sancycline [inn]
26. Sancycline (usan/inn)
27. Sancycline [usan]
28. Dsstox_cid_31625
29. Dsstox_rid_97509
30. Dsstox_gsid_57836
31. Schembl112644
32. Schembl1649653
33. Chembl2009312
34. Dtxsid5057836
35. Schembl23271182
36. Ex-a210
37. Chebi:135671
38. Tox21_113907
39. S5859
40. Zinc22066481
41. Akos022186417
42. Akos037517260
43. Zinc103941901
44. Cs-5602
45. Bonomycin;6-demethyl-6-deoxytetracycline
46. Ncgc00262909-01
47. 4beta-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12abeta-tetrahydroxy-1,11-dioxo-2-naphthacencarboxamid
48. Bs-22405
49. Cas-808-26-4
50. Hy-17466
51. Nci60_004256
52. D05796
53. 808s264
54. A864642
55. Q27285586
56. (4s,4as,12as)-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
57. (4s,4as,5ar,12as)-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide
58. (4s,4as,5ar,12as)-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide
59. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4s-(4alpha,4aalpha,5aalpha,12aalpha))-
60. 4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-napththacenecarboxamide, Hydrochloride
Molecular Weight | 414.4 g/mol |
---|---|
Molecular Formula | C21H22N2O7 |
XLogP3 | 1.2 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 2 |
Exact Mass | 414.14270105 g/mol |
Monoisotopic Mass | 414.14270105 g/mol |
Topological Polar Surface Area | 161 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 892 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11842
Submission : 1996-01-26
Status : Inactive
Type : II
Market Place
Reply
15 Oct 2020
Reply
14 Dec 2017
ABOUT THIS PAGE
100
PharmaCompass offers a list of Sancycline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sancycline manufacturer or Sancycline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sancycline manufacturer or Sancycline supplier.
PharmaCompass also assists you with knowing the Sancycline API Price utilized in the formulation of products. Sancycline API Price is not always fixed or binding as the Sancycline Price is obtained through a variety of data sources. The Sancycline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_31625 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_31625, including repackagers and relabelers. The FDA regulates DSSTox_CID_31625 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_31625 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A DSSTox_CID_31625 supplier is an individual or a company that provides DSSTox_CID_31625 active pharmaceutical ingredient (API) or DSSTox_CID_31625 finished formulations upon request. The DSSTox_CID_31625 suppliers may include DSSTox_CID_31625 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_31625 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DSSTox_CID_31625 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_CID_31625 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_CID_31625 DMFs exist exist since differing nations have different regulations, such as DSSTox_CID_31625 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DSSTox_CID_31625 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_CID_31625 USDMF includes data on DSSTox_CID_31625's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_CID_31625 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DSSTox_CID_31625 suppliers with USDMF on PharmaCompass.
DSSTox_CID_31625 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_31625 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_31625 GMP manufacturer or DSSTox_CID_31625 GMP API supplier for your needs.
A DSSTox_CID_31625 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_31625's compliance with DSSTox_CID_31625 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_31625 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_31625 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_31625 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_31625 EP), DSSTox_CID_31625 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_31625 USP).